Skip to main content

Table 4 Prescribing practices

From: “No generics, Doctor!” The perspective of general practitioners in two French regions

 

N

%

95% CI

In your routine practice, what are your prescribing choices in regard to generics or originators? (Only one possible answer)

 It depends on the situation

233

73.7

70.7–76.6

 I prescribe only generics or by INN a

50

15.8

13.5–18.4

 I prescribe only originators

33

10.4

8.4–12.9

You answered, “It depends on the situation”. Can you expand on this response? (Several possible answers)

 I prescribe an originator if the patient asks for it, even without a reason

110

34.8

31.4–38.3

 A priori, I systematically prescribe an originator for certain drugs

89

28.2

25.0–31.5

 A priori, I systematically prescribe an originator for fragile patients

61

19.3

16.6–22.3

 I prescribe an originator on a case-by-case basis if the patient reports adverse effects

50

15.8

13.4–18.6

 I mainly prescribe by INN a

36

11.4

9.3–13.9

 A priori, I systematically prescribe an originator for certain diseases

31

9.8

7.9–12.2

 I prescribe an originator on a case-by-case basis if I observe adverse effects

22

7.0

5.3–9.0

 I prescribe by INN a with the name of the originator in brackets

22

7.0

5.3–9.0

 I prescribe by INN a or a generic as the initial prescription

10

3.2

2.1–4.7

 I prescribe an originator on a case-by-case basis if the patient says that the generic was not effective

8

2.5

1.6–4.0

 I prescribe an originator on a case-by-case basis if I see that the generic was not effective

7

2.2

1.4–3.6

  1. aINN, International Non-proprietary Name